Building and optimizing a virus-specific T cell receptor library for targeted immunotherapy in viral infections

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Banu, Nasirah ^a   Chia, Adeline ^a   Ho, Zi Zong ^a   Garcia, Alfonso Tan ^a   Paravasivam, Komathi ^a   Grotenbreg, Gijsbert M ^b   Bertoletti, Antonio ^a,b   Gehring, Adam J ^a,c,d  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CELL LINE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MOLECULARLY TARGETED THERAPY; T LYMPHOCYTE; VIRUS INFECTION;

CELL LINE; GENETIC THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; MOLECULAR TARGETED THERAPY; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; VIRUS DISEASES;

EID: 84894754369     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04166     Document Type: Article

References (39)

1. Bertoletti, A. & Ferrari, C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61, 1754-1764 (2012).
2. Pagliara, D. & Savoldo, B. Cytotoxic T lymphocytes for the treatment of viral infections and posttransplant lymphoproliferative disorders in transplant recipients. Curr Opin Infect Dis 25, 431-437 (2012).
3. Lau, G. K. et al. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 25, 1497-1501 (1997). (Pubitemid 27250775)
4. Lau, G. K. K. et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 122, 614-624 (2002). (Pubitemid 34173812)
5. Loggi, E. et al. Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft. J. Hepatol. 50, 625-630 (2009).
6. Cobbold, M. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202, 379-386 (2005). (Pubitemid 41126955)
7. Rooney, C. M. et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92, 1549-1555 (1998). (Pubitemid 28406858)
8. Kreijtz, J. H. C. M. et al. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 1-7 (2009). doi:10.1016/j.vaccine.2009.05.079.
9. Sridhar, S. et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 19, 1305-1312 (2013).
10. Oh, H. L. J. et al. Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope. J. Virol. 85, 10464-10471 (2011).
11. Gehring, A. J. et al. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. J. Hepatol. 55, 103-110 (2011).
12. Sung, W.-K. et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44, 765-769 (2012).
13. Szymczak, A. L. et al. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22, 589-594 (2004). (Pubitemid 38585911)
14. Yang, S. et al. Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition. Gene Ther 15, 1411-1423 (2008).
15. Kuball, J. et al. Facilitating matched pairing and expression of TCR chains introduced into human T cells. Blood 109, 2331-2338 (2007). (Pubitemid 46425872)
16. Cohen, C. J. et al. Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide Bond. Cancer Res 67, 3898-3903 (2007). (Pubitemid 46762178)
17. Scholten, K. B. J. et al. Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells. Clin. Immunol. 119, 135-145 (2006).
18. Engels, B. et al. Retroviral vectors for high-level transgene expression in T lymphocytes. Hum. Gene Ther. 14, 1155-1168 (2003). (Pubitemid 36930405)
19. Leisegang, M. et al. Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. J Mol Med 86, 573-583 (2008).
20. Caron,G. et al.Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-c production by memory CD41 T cells. J. Immunol. 175, 1551-1557 (2005). (Pubitemid 41023056)
21. Zhu, Q. et al. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J. Clin. Invest. 120, 607-616 (2010).
22. Haga-Friedman, A., Horovitz-Fried, M. & Cohen, C. J. Incorporation of Transmembrane Hydrophobic Mutations in the TCR Enhance Its Surface Expression and T Cell Functional Avidity. J. Immunol. 188, 5538-5546 (2012).
23. Okamoto, S. et al. Improved Expression and Reactivity of Transduced Tumor-Specific TCRs in Human Lymphocytes by Specific Silencing of Endogenous TCR. Cancer Res 69, 9003-9011 (2009).
24. Aggen, D. H. et al. Single-chain VaVb T-cell receptors function without mispairing with endogenous TCR chains. Gene Ther 19, 365-374 (2011).
25. Sommermeyer, D. & Uckert, W. Minimal Amino Acid Exchange in Human TCR Constant Regions Fosters Improved Function of TCR Gene-Modified T Cells. J. Immunol. 184, 6223-6231 (2010).
26. Bialer, G., Horovitz-Fried,M., Ya'acobi, S., Morgan, R. A. & Cohen, C. J. Selected Murine Residues Endow Human TCR with Enhanced Tumor Recognition. J. Immunol. 184, 6232-6241 (2010).
27. Voss, R.-H. et al. Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells. J. Immunol. 180, 391-401 (2008).
28. Sebestyén, Z. et al. Human TCR that incorporate CD3f induce highly preferred pairing between TCRa and b chains following gene transfer. J. Immunol. 180, 7736-7746 (2008).
29. Cohen, C. J. Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 Stability. Cancer Res 66, 8878-8886 (2006). (Pubitemid 44449206)
30. Yang, S. et al.Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails. Cancer Immunol Immunother 62, 727-736 (2012).
31. Hinrichs, C. S. et al. Adoptively transferred effector cells derived from naive rather than central memory CD81 T cells mediate superior antitumor immunity. Proc. Natl. Acad. Sci. U.S.A. 106, 17469-17474 (2009).
32. Koh, S. et al. A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus. Mol Ther Nucleic Acids 2, e114 (2013).
33. Kearse, K. P. et al. Developmental regulation of alpha beta T cell antigen receptor expression results from differential stability of nascent TCR alpha proteins within the endoplasmic reticulum of immature and mature T cells. EMBO J. 13, 4504 (1994).
34. Bonifacino, J. S., Suzuki, C. K. & Klausner, R. D. A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science 247, 79-82 (1990).
35. Shin, J., Lee, S. & Strominger, J. L. Translocation of TCR alpha chains into the lumen of the endoplasmic reticulum and their degradation. Science 259, 1901-1904 (1993). (Pubitemid 23124462)
36. Labrecque, N. et al. How Much TCR Does a T Cell Need? Immunity 15, 71-82 (2001). (Pubitemid 32728321)
37. Arber, C. et al. The immunogenicity of virus-derived 2A sequences in immunocompetent individuals. Gene Ther (2013). doi:10.1038/gt.2013.25.
38. Leen, A. M. et al.Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 121, 5113-5123 (2013).
39. Chang, C. X. L. et al. Conditional ligands for Asian HLA variants facilitate the definition of CD8 1T-cell responses in acute and chronic viral diseases. Eur. J. Immunol. 43, 1109-1120 (2013).